Rifampicine Labatec 150 mg
Rifampicine Labatec 150 mg is a medicine authorised by Swissmedic under authorisation number 50264. The authorisation holder is Labatec Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 11 August 1989 and the authorisation is valid without a time limit. ATC code J04AB02 places the medicine in the group Antimycobacterials.
| Authorisation number | 50264 |
|---|---|
| Name | Rifampicine Labatec 150 mg |
| Full name | Rifampicine Labatec 150 mg, gélules |
| Authorisation holder | Labatec Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J04AB02 |
| First authorisation | 11 August 1989 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rifampicine Labatec 150 mg, gélules | A | 11 August 1989 |
| 2 | Rifampicine Labatec 300 mg, gélules | A | 11 August 1989 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | Kapsel(n) | J04AB02 | 08.02.1. | A |
| 17 | 80 | Kapsel(n) | J04AB02 | 08.02.1. | A |
| 2 | 40 | Kapsel(n) | J04AB02 | 08.02.1. | A |
| 3 | 10 | Kapsel(n) | J04AB02 | 08.02.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rifampicine Labatec 150 mg authorised in Switzerland?
Yes. Rifampicine Labatec 150 mg is authorised by Swissmedic under authorisation number 50264, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Rifampicine Labatec 150 mg have?
Rifampicine Labatec 150 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Rifampicine Labatec 150 mg?
The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.